American Council on Science and Health3d
The FDA Finally Removes a Huge Barrier to an Effective Schizophrenia Medicine
For 35 years, the FDA has placed onerous restrictions on the only drug it has ever approved for treatment-resistant ...
Medscape9d
FDA Ended Clozapine REMS. But Will It Increase Prescribing?
Advocates and clinicians say that patients are still having trouble getting refills, even though the FDA has lifted REMS for ...
Trump’s pick to lead FDA tells senators he’d look into food, abortion pill, vaccine advisers
President Donald Trump’s pick to lead the US Food and Drug Administration told senators in a tense confirmation hearing ...
Jezebel7d
Trump’s FDA Nominee Squirmed During Questions on Medication Abortion
Marty Makary wouldn't commit to maintaining current access to mifepristone during his Senate confirmation hearing on Thursday ...
WRVO Public Media6d
5 takeaways from the confirmation hearing for Trump's FDA nominee
Dr. Marty Makary, President Trump's pick to run the Food and Drug Administration, faced questions from the Senate HELP ...
The Grand Junction Daily Sentinel13d
FDA Makes Access to Clozapine Easier for Patients With Schizophrenia
"Although the risk of severe neutropenia with clozapine still exists, FDA has determined that the REMS program for clozapine ...
4 Takeaways from Martin Makary’s Confirmation Hearing to Lead FDA
Dr. Marty Makary, nominee to be commissioner of the U.S. Food and Drug Administration (FDA), appears before the Senate Health ...
FDA Approves Expanded Use of Eculizumab (Soliris) for Pediatric Myasthenia Gravis, Bringing New Treatment Options for Children
The Muscular Dystrophy Association (MDA) welcomes the U.S. Food and Drug Administration (FDA) approval of the expanded indication of Alexion/AstraZeneca’s eculizumab (Soliris) for pediatric patients ...
CNN7d
Trump’s pick to lead FDA tells senators he’d look into food, abortion pill, vaccine advisers
If confirmed as FDA commissioner, Makary will report to ... which is required to be collected as a part of the REMS program, the Risk Evaluation and Mitigation Strategy,” Makary said in the ...
U.S. News & World Report13d
FDA Makes Access to Clozapine Easier for Patients With Schizophrenia
FDA Makes Access to Clozapine Easier for Patients With Schizophrenia By Stephanie Brown HealthDay Reporter FRIDAY, Feb. 28, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...